Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia

Lara M. Gómez García, Adela Escudero, Carmen Mestre‐Durán, J.L. Fuster Soler, Antonia Pascual Martínez, José Manuel Vagace, María Vela, Beatriz Ruz-Caracuel, Alfonso Navarro‐Zapata, Lucía Fernández, Adrián Fernández, Alejandra Leivas, Joaquín Martínez‐López, Cristina Ferreras, Raquel de Paz, Miguel Blanquer, Víctor Galán‐Gómez, Berta González, Dolores Corral, Luisa Sisinni, Isabel Mirones, A. Balas, José L. Vicário, Paula Valle, Alberto M. Borobia, Antonio Pérez‐Martínez